Skip to content

Melatonin As an Analgesic in Preterm Neonate

Efficacy of Melatonin As an Analgesic in Preterm Neonate

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05971485
Enrollment
40
Registered
2023-08-02
Start date
2022-08-20
Completion date
2024-10-30
Last updated
2025-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Neonate Analgesia

Keywords

Preterm, Analgesia, Melatonin, Oxidative stress

Brief summary

Melatonin (N-acetyl-5-methoxytryptamine) is a neurohormone secreted by the pineal gland with several important functions, including regulation of the circadian rhythms, antioxidant and anti-inflammatory effects, accumulating evidence revealed that it also plays an important role in pain modulation through multiple mechanisms. The investigators aimed to evaluate the analgesic effect of enteral melatonin given 30 minutes before cannula insertion in preterm neonates by assessing Premature Infant pain Profile score (PIPP) before and 5 minutes after the procedure. Additionally, the study aimed to explore the relationship between procedural pain and oxidative stress, along with the effectiveness of pain management of melatonin by measuring Malondialdehyde (MDA), a well-accepted marker of oxidative stress, 60 minutes after the procedure.

Detailed description

This is a randomized, double-blind, controlled trial

Interventions

Melatonin 10 mg will be used. 5 mg·kg-1 dissolved in 2 ml of distilled water via enteral route in one single dose 30 minutes before the venous cannula insertion

OTHERPlacebo

The placebo group will receive 2 ml of distilled water as a placebo 30 minutes before venous cannula insertion.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
No minimum to 28 Days
Healthy volunteers
No

Inclusion criteria

* Preterm infant * less than 37 weeks gestational age * who started enteral feeding.

Exclusion criteria

* Multiple congenital anomalies. * Facial malformation. * Receiving analgesia or sedation. * Contraindication of enteral feeding. * Clinical or laboratory signs of sepsis. * Infants with high oxygen needs either on invasive or non-invasive mechanical ventilation.

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the analgesic effect of melatonin in preterm5 minutes starting just before cannula insertion to 5 minutes after the procedureEvaluate the analgesic effect of melatonin during venous cannula insertion in preterm neonates by assessing Premature Infant pain Profile score (PIPP) before and 5 minutes after the procedure. Premature Infant pain Profile score (PIPP) scale 0-21, with 0-6 reflecting no pain, 6-12 reflecting mild-moderate pain, and above 12 indicating severe pain
Malondialdehyde (MDA), marker of oxidative stress60 minutes of the procedureSerum Malondialdehyde (MDA), a marker of oxidative stress through measuring serum MDA after 60 minutes of the procedure

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026